Cancer Research Annual Meeting 2010  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 3689-3697, August 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beretta, G. L.
Right arrow Articles by Capranico, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beretta, G. L.
Right arrow Articles by Capranico, G.
[Cancer Research 59, 3689-3697, August 1, 1999]
© 1999 American Association for Cancer Research


Experimental Therapeutics

Tethering a Type IB Topoisomerase to a DNA Site by Enzyme Fusion to a Heterologous Site-selective DNA-binding Protein Domain1

Giovanni Luca Beretta, Monica Binaschi, Emanuela Zagni, Luisa Capuani and Giovanni Capranico2

Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, 20133 Milan [G. L. B., M. B., E. Z., L. C., G. C.]; and Department of Biochemistry "Moruzzi," University of Bologna, 40126 Bologna [G. C.], Italy

Topoisomerase IB (Top1) has essential functions in higher eukaryotes, but effective anticancer agents can transform it into a lethal DNA-cleaving toxin. Fusion of the yeast Gal4 DNA-binding protein domain (amino acids 1–105; Gal4DBD) to the NH2 terminus of full-length human Top1 results in a GalTop chimera that maintains basic properties of the two parent proteins. DNA cleavage and binding activities of GalTop were then compared to Top1 to establish whether the fusion protein had altered site specificity. Under conditions of reduced binding of Top1 to DNA, Gal4DBD was able to selectively anchor the chimera on a template containing a Gal4 consensus motif, thus bringing Top1 to cleave 20–40-bp sequences close to the Gal4 motif with high specificity. Footprinting analyses showed that the chimera protected a DNA region that was wider than that protected by a Gal4DBD protein fragment, consistent with the cleavage results. The data demonstrate that a Top1 can be targeted to a specific DNA site by protein fusion to a heterologous DNA-binding domain. Such hybrid topoisomerase-derived enzymes may be useful for directing Top1 activity to specific genomic loci in living cells.




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
H. Murakami and A. Nicolas
Locally, Meiotic Double-Strand Breaks Targeted by Gal4BD-Spo11 Occur at Discrete Sites with a Sequence Preference
Mol. Cell. Biol., July 1, 2009; 29(13): 3500 - 3516.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. L. Beretta, G. Petrangolini, M. De Cesare, G. Pratesi, P. Perego, S. Tinelli, M. Tortoreto, M. Zucchetti, R. Frapolli, E. Bello, et al.
Biological Properties of IDN5174, a New Synthetic Camptothecin with the Open Lactone Ring.
Cancer Res., November 15, 2006; 66(22): 10976 - 10982.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Moore, A. Klug, and Y. Choo
From the Cover: Improved DNA binding specificity from polyzinc finger peptides by using strings of two-finger units
PNAS, February 13, 2001; 98(4): 1437 - 1441.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.